FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029673669> ?p ?o ?g. }

• W2029673669 endingPage "1518" @default.
• W2029673669 startingPage "1514" @default.
• W2029673669 abstract "In view of the superior T-cell depletion and prolonged half-life of thymoglobulin, we initiated a protocol to administer thymoglobulin intermittently based on peripheral blood CD3+ lymphocyte counts.In this prospective study, 41 consecutive high-risk cadaver transplant recipients (panel reactive antibody level >30%, repeat transplant recipients, simultaneous pancreas and kidney or pancreas after kidney recipients, prolonged cold-ischemia time, prolonged donor hypotension, non-heart-beating donors) who received thymoglobulin induction therapy were included. The first dose (1.5 mg/kg) of thymoglobulin was administered intraoperatively. CD3+ lymphocyte count in the peripheral blood was determined daily and repeat doses were administered when the CD3+ count was >20 cells/mm3. Calcineurin inhibitors (CI) in low doses were introduced when the allograft function recovered and the serum creatinine level dropped by at least 25% from the pretransplant level. Thymoglobulin treatment was discontinued once therapeutic CI drug levels were achieved. Concomitant immunosuppression consisted of mycophenolate mofetil and prednisone.The mean individual thymoglobulin dose was 104 mg (1.4 mg/kg), and the total cumulative dose per patient was 318 mg (4.2 mg/kg). Patients received an average of three doses and a mean of six CD3 counts were obtained per patient. Introduction of CI was delayed for an average of 6 days posttransplantation. At a mean follow-up of 340 days, two (4.9%) patients died; three (7.3%) renal allografts and two (18.2%) pancreas allografts were lost. Five (12.2%) patients developed a total of six acute rejection episodes. The mean serum creatinine in the 38 patients with a functioning kidney was 1.47 mg/dl, and the mean blood glucose in the 9 pancreas allograft recipients was 89 mg/dl. Cytomegalovirus (CMV) infection occurred in one (2.4%) patient. No posttransplant lymphoproliferative disorders were seen in this patient cohort. The hospital pharmacy charge for a 100-mg dose of thymoglobulin at this center was $2,165, and the laboratory charge for a single CD3 determination was $70. In this study, the average charges per patient for the total dose of thymoglobulin and six CD3 determinations were $7305. In comparison, the charge for daily administration of 104 mg of thymoglobulin (which was the mean dose) for 6 days (mean time to CI therapy initiation) would be $13,510 and for 10 days (mean time to therapeutic CI levels) would be $22,516. This represents a savings of 46% and 68%, respectively.Intermittent thymoglobulin therapy, based on peripheral blood CD3+ lymphocyte counts, is safe and associated with low acute rejection rate in high-risk kidney and kidney-pancreas transplant recipients. A mean of three doses resulted in adequate suppression of CD3+ lymphocytes permitting delayed introduction of CI in low doses until recovery of renal function occurred. When compared to traditional daily administration, intermittent therapy results in significant cost savings and reduces the total cumulative dose of this potent immunosuppressive agent." @default.
• W2029673669 created "2016-06-24" @default.
• W2029673669 creator A5024834856 @default.
• W2029673669 creator A5026208455 @default.
• W2029673669 creator A5027751857 @default.
• W2029673669 creator A5040860793 @default.
• W2029673669 creator A5072307917 @default.
• W2029673669 date "2002-05-01" @default.
• W2029673669 modified "2023-10-04" @default.
• W2029673669 title "Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients" @default.
• W2029673669 cites W1989390667 @default.
• W2029673669 cites W1999246730 @default.
• W2029673669 cites W2018100390 @default.
• W2029673669 cites W2041489270 @default.
• W2029673669 cites W2121454052 @default.
• W2029673669 cites W2127596128 @default.
• W2029673669 doi "https://doi.org/10.1097/00007890-200205150-00025" @default.
• W2029673669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12023634" @default.
• W2029673669 hasPublicationYear "2002" @default.
• W2029673669 type Work @default.
• W2029673669 sameAs 2029673669 @default.
• W2029673669 citedByCount "102" @default.
• W2029673669 countsByYear W20296736692012 @default.
• W2029673669 countsByYear W20296736692013 @default.
• W2029673669 countsByYear W20296736692014 @default.
• W2029673669 countsByYear W20296736692015 @default.
• W2029673669 countsByYear W20296736692016 @default.
• W2029673669 countsByYear W20296736692017 @default.
• W2029673669 countsByYear W20296736692018 @default.
• W2029673669 countsByYear W20296736692019 @default.
• W2029673669 countsByYear W20296736692020 @default.
• W2029673669 countsByYear W20296736692021 @default.
• W2029673669 countsByYear W20296736692022 @default.
• W2029673669 countsByYear W20296736692023 @default.
• W2029673669 crossrefType "journal-article" @default.
• W2029673669 hasAuthorship W2029673669A5024834856 @default.
• W2029673669 hasAuthorship W2029673669A5026208455 @default.
• W2029673669 hasAuthorship W2029673669A5027751857 @default.
• W2029673669 hasAuthorship W2029673669A5040860793 @default.
• W2029673669 hasAuthorship W2029673669A5072307917 @default.
• W2029673669 hasBestOaLocation W20296736691 @default.
• W2029673669 hasConcept C126322002 @default.
• W2029673669 hasConcept C126894567 @default.
• W2029673669 hasConcept C141071460 @default.
• W2029673669 hasConcept C2777630719 @default.
• W2029673669 hasConcept C2778720950 @default.
• W2029673669 hasConcept C2780091579 @default.
• W2029673669 hasConcept C2780252810 @default.
• W2029673669 hasConcept C2780303639 @default.
• W2029673669 hasConcept C2780306776 @default.
• W2029673669 hasConcept C2911091166 @default.
• W2029673669 hasConcept C71924100 @default.
• W2029673669 hasConcept C90924648 @default.
• W2029673669 hasConceptScore W2029673669C126322002 @default.
• W2029673669 hasConceptScore W2029673669C126894567 @default.
• W2029673669 hasConceptScore W2029673669C141071460 @default.
• W2029673669 hasConceptScore W2029673669C2777630719 @default.
• W2029673669 hasConceptScore W2029673669C2778720950 @default.
• W2029673669 hasConceptScore W2029673669C2780091579 @default.
• W2029673669 hasConceptScore W2029673669C2780252810 @default.
• W2029673669 hasConceptScore W2029673669C2780303639 @default.
• W2029673669 hasConceptScore W2029673669C2780306776 @default.
• W2029673669 hasConceptScore W2029673669C2911091166 @default.
• W2029673669 hasConceptScore W2029673669C71924100 @default.
• W2029673669 hasConceptScore W2029673669C90924648 @default.
• W2029673669 hasIssue "9" @default.
• W2029673669 hasLocation W20296736691 @default.
• W2029673669 hasLocation W20296736692 @default.
• W2029673669 hasOpenAccess W2029673669 @default.
• W2029673669 hasPrimaryLocation W20296736691 @default.
• W2029673669 hasRelatedWork W1486584413 @default.
• W2029673669 hasRelatedWork W2050221135 @default.
• W2029673669 hasRelatedWork W2079944473 @default.
• W2029673669 hasRelatedWork W2087086071 @default.
• W2029673669 hasRelatedWork W2117376546 @default.
• W2029673669 hasRelatedWork W2135058494 @default.
• W2029673669 hasRelatedWork W2604771942 @default.
• W2029673669 hasRelatedWork W2774938021 @default.
• W2029673669 hasRelatedWork W3088212660 @default.
• W2029673669 hasRelatedWork W4319240156 @default.
• W2029673669 hasVolume "73" @default.
• W2029673669 isParatext "false" @default.
• W2029673669 isRetracted "false" @default.
• W2029673669 magId "2029673669" @default.
• W2029673669 workType "article" @default.